Market Intelligence Ecosystem
Gufic Biosciences Limited (NSE:GUFICBIO) Q2 FY23 Earnings Concall dated Nov.13, 2022 Corporate Participants: Ami Naresh Shah -- Company Secretary and Compliance Officer Avik Das -- Investor
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Raj Kumar Baheti -- Director - Finance and Chief Financial
MedPlus Health Services Ltd (NSE:MEDPLUS) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Gangadi Madhukar Reddy -- Managing Director and Chief Executive Officer Prasad
Healthcare Global Enterprises Ltd (NSE:HCG) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: B.S. Ajai Kumar -- Executive Chairman Raj
Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Suneeta Reddy -- Managing Director Krishnan
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Bhaskar Rao Bollineni -- Founder
Dishman Carbogen Amcis Ltd (NSE: DCAL) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Arpit Vyas -- Global Managing Director Pascal Villemagne -- Vice
Alkem Laboratories Ltd (NSE:ALKEM) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Amit Kumar Khandelia -- Assistant Vice President, Finance
Supriya Lifescience Ltd (NSE:SUPRIYA) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rasika Sawant -- Investor Relation Partner Satish Wagh
Narayana Hrudayalaya Limited (NSE:NH) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Unidentified Speaker -- Emmanuel Rupert -- Managing Director
https://youtu.be/-5pgj3qU44c Key highlights from Sequent Scientific Limited (SEQUENT) Q2 FY23 Earnings Concall Q&A Highlights: [00:17:40] Rishab Jain asked about Tineta Pharma acquisition,
Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Yash Prithviraj Mutha C.A. -- Whole-Time Director Pawan
https://youtu.be/lAaNZKEvjOc Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:43] Rahul Agarwal with Incred Capital enquired
Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability during the
Key highlights from Cipla Limited (CIPLA) Q2 FY23 Earnings Concall Management Update: [00:02:21] CIPLA reported the highest quarterly revenue historically of INR5,829
Solara Active Pharma Sciences Limited (NSE:SOLARA) Q2 FY23 Earnings Concall dated Nov. 09, 2022 Corporate Participants: Abhishek Singhal -- Investor Relations Jithesh Devendra -- Managing Director
Sequent Scientific Limited (NSE:SEQUENT) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate Participants: Abhishek Singhal -- Head of Investor Relations Rajaram
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate participants: Arvind Lal -- Executive Chairman Om Prakash
Metropolis Healthcare Limited (NSE:METROPOLIS) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate Participants: Ameera Shah -- Managing Director Rakesh Agarwal --
https://youtu.be/e1-tljnhSVM Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY23 Earnings Concall Management Update: [00:06:48] DIVISLAB stated that though global logistics scenario
Divi's Laboratories Ltd.'s revenues in Q2FY23 fell 7% to ₹ 1,855 crores. Consolidated Profit came at ₹ 494 crores showcasing a 19%